2018
DOI: 10.3345/kjp.2018.61.5.156
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis

Abstract: PurposeSepsis is a major cause of neonatal morbidity and mortality. Early diagnosis is a major problem because of the lack of specific clinical signs. Therefore, a reliable diagnostic marker is needed to guide the use of antimicrobial agents. The objective of our study was to assess the value of proadrenomedullin (pro-ADM) in establishing the diagnosis and evaluating the prognosis of neonatal sepsis.MethodsThis study enrolled 60 newborn infants with sepsis proven with positive blood cultures and 30 healthy neo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
13
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 16 publications
3
13
0
Order By: Relevance
“…Although several studies have evaluated new markers or their combinations, most only address a specific infectious disease or specimen type, and thus do not allow generalization. In addition, patients with mild/localized infections or severe infections complicated by systemic involvement may display different levels of such biomarkers in serum [ 55 , 65 ]. Last but not least, underlying diseases (e.g., immunodeficiency or cancer) may impact on the performance of biomarkers because their levels generally rise in response to different inflammatory processes [ 46 , 66 ].…”
Section: Biomarker Combinationsmentioning
confidence: 99%
“…Although several studies have evaluated new markers or their combinations, most only address a specific infectious disease or specimen type, and thus do not allow generalization. In addition, patients with mild/localized infections or severe infections complicated by systemic involvement may display different levels of such biomarkers in serum [ 55 , 65 ]. Last but not least, underlying diseases (e.g., immunodeficiency or cancer) may impact on the performance of biomarkers because their levels generally rise in response to different inflammatory processes [ 46 , 66 ].…”
Section: Biomarker Combinationsmentioning
confidence: 99%
“…Sepsis and septic shock are life-threatening medical emergencies characterized by severe systemic inflammation and organ dysfunction due to an excessive response to infections that may lead to death [ 1 , 2 , 3 , 4 , 5 , 6 ]. The definition of sepsis includes a dysregulated systemic inflammation, acute multi-organ dysfunction (i.e., cardiovascular, respiratory, and renal systems), and a deregulated immune response to a microbial invasion of the blood that is responsible of organ failure [ 7 , 8 , 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…In neonates, especially if preterm, levels of ProADM are physiologically elevated, requiring cut-off values for infection that are higher than those set in older children. Two different cut-offs (3.9 nmol/L and 4.3 nmol/L) [10,20] were significantly related to EOS, and, similarly to PCT, the ProADM trend in the first three days of life was a good predictor of neonatal mortality.…”
Section: Discussionmentioning
confidence: 88%
“…In this study, 4.3 nmol/L was identified as the optimal cut-off for ProADM: this value had a sensitivity of 93.3% and a specificity of 86.7%. The ProADM levels were also significantly higher in non-survivors (p = 0.001) [20].…”
Section: Neonatal Sepsismentioning
confidence: 89%
See 1 more Smart Citation